Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1988-12-15
1989-08-15
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 3144
Patent
active
048575330
ABSTRACT:
A method of treating a human or animal patient suffering from an autoimmune disease comprises daily administration to such patient of from about 1 to about 100 mg of the narcotic antagonists nalmefene or naltrexone. The nalmefene or naltrexone may be administered in equally divided doses from one to four times daily, preferably by the oral route. Parenteral administration may be utilized where suitable.
REFERENCES:
Chem. Abst. 100 (1984)-80084b-1.
Chem. Abst. 108 (1988)-143338a.
Rios et al., Eur. J. Pharm., 96:277-289 (1983).
Kayser et al., Proceedings of the Vth World Congress on Pain, pp. 72-79 (Elsevier Science Publishers 1988).
Hargreaves et al., Proceedings of the Vth World Congress on Pain, pp. 55-60 (Elsevier Science Publishers 1988).
Atkinson David C.
Sherman Fred P.
Baker Cummins Pharmaceuticals, Inc.
Friedman Stanley J.
LandOfFree
Method of treatment for autoimmune diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treatment for autoimmune diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treatment for autoimmune diseases will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-121893